Top 4 search results for "avmapki fakzynja co-parp" in Treatments. To see all results and access other features, sign up for free.

Avmapki Fakzynja Co-Pack (Avutometinib/Defactinib)

Overview

Avmapki Fakzynja Co-Pack is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with recurrent low-grade serous ovarian cancer (LGSOC) that has a mutation (change) in the KRAS gene…

Zejula (Niraparib)

Overview
Zejula is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adults with advanced or recurrent epithelial ovarian cancer who are in a complete or… read more

Rubraca (Rucaparib)

Overview
Rubraca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adult patients with recurrent epithelial ovarian cancer who are in a complete or partial… read more

Lynparza (Olaparib)

Overview
Lynparza is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat deleterious germline or somatic BRCA-mutated advanced ovarian cancer who are in complete or partial response to… read more